Labcorp projects upbeat annual profit on strong diagnostic test demand

Labcorp expects 2026 earnings to exceed estimates as demand for diagnostic tests remains high. The company also beat quarterly profit targets earlier today.

洞察:
Labcorp Holdings Inc. announced on Tuesday, February 17, 2026, that it has revised its 2026 financial outlook, forecasting annual adjusted profit above Wall Street estimates. The company, which operates primarily in the US USUS, cited robust demand for diagnostic tests as the primary driver for the updated guidance. This revision places the company’s adjusted earnings per share (EPS) midpoint above the average expectations of analysts, reflecting ongoing revenue and market-share expansion in laboratory diagnostics.
The logo for Labcorp, Laboratory Corporation of America, a life sciences company is displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., June 22, 2023. REUTERS/Brendan McDermid
The logo for Labcorp, Laboratory Corporation of America, a life sciences company is displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., June 22, 2023. REUTERS/Brendan McDermid